169ACTIVITIES
5ORGS REPRESENTED
4BILLS
Revolving door — covered positions
Federal positions Margaret held before / during the 2-year LDA window. This is the credibility signal — who they were inside the building before they started lobbying it.
Senior FDA Policy Advisor, Senate Health, Education, Labor and Pensions Committee
Health Policy Assistant, Sen. Richard Burr
Organizations represented
5Orgs whose LD-2 filings list Margaret as an active lobbyist, sorted by activity volume.
Topics in Filings
22Policy topics Margaret files on across all their LD-2 activities.
ORPHAN Cures Act×45
Rare Pediatric Disease Priority Review Voucher Program reauthorization×30
Give Kids a Chance Act×30
IRA implementation. 340B×30
Orphan drugs×30
Supply chain×30
Vaccine policy×30
Medicare policies×16
Trade policies×16
Medicare and Medicaid payment and coverage issues×15
340B drug discount program×15
General issues×15
Show all 22 topics (+10 more) ▾
One Big Beautiful Bill Act, provisions impacting pharmaceuticals×10
National security issues×10
Intellectual property protections and enforcement×10
Biopharmaceutical patent policy×10
EPIC Act×10
Federal proposals and policies×4
Impacting the innovative biotechnology industry, including: health care policies×4
Medicare payment, coverage, and reimbursement×4
Drug pricing and supply chain issues×4
Legislative and regulatory proposals and policies×3
Issue mix
LDA general-issue codes weighted by activity count.
Health Issues39
Medical/Disease Research/Clinical Labs31
Pharmacy29
Medicare/Medicaid27
Budget/Appropriations11
Defense11
Trade (domestic/foreign)11
Copyright/Patent/Trademark10